戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1                            Here we show that resistance to 5FC in Cryptococcus deuterogattii is acqui
2  advantage attributable to production of and resistance to a diffusible compound that inhibits growth
3 ter the resident Mphi subset composition and resistance to a subsequent infection.
4 ells present polyamine uptake deficiency and resistance to a toxic polyamine biosynthesis inhibitor m
5 rs MxA and MxB are large GTPases that convey resistance to a variety of infectious viruses.
6 esults in decreased cell width and increased resistance to A22, a small-molecule inhibitor of MreB as
7                           However, increased resistance to ACT highlights the importance of finding n
8 rphologically distinct, and characterized by resistance to activation compared to CAV1- Hu-MuSCs.
9   Influential physicians willing to overcome resistance to advances were able to bring medical practi
10                    Determining mechanisms of resistance to alphaPD-1/PD-L1 immune-checkpoint immunoth
11 nses in biomineralization as a mechanism for resistance to altered environmental conditions and preda
12                                   Phenotypic resistance to amoxicillin in three isolates correlated w
13 ranted to better define mutations conferring resistance to amoxicillin, tetracycline, and rifampin, b
14  the frequency of multidrug resistance (MDR)(resistance to ampicillin, cotrimoxazole, and chloramphen
15 s may have selected for tolerance instead of resistance to an important pathogen.
16 ocrine response that underlies breast cancer resistance to anti-estrogen treatments.
17 eport that describes HPV E5 as a mediator of resistance to anti-PD-1/PD-L1 immunotherapy and demonstr
18   This study identifies a novel mechanism of resistance to anti-PD-1/PD-L1 immunotherapy mediated by
19 TGFB superfamily, represents a mechanism for resistance to anti-PD1 therapy in preclinical models and
20 d intestinal cell types were associated with resistance to anti-TNF therapy.
21 tems are necessary for metabolic regulation, resistance to antibiotics and antimicrobials, pathogenes
22        The emergence of superbugs developing resistance to antibiotics and the resurgence of microbia
23                                    Bacterial resistance to antibiotics in this clinical setting furth
24  prevalent pathogen that can rapidly acquire resistance to antibiotics.
25                                 Response and resistance to anticancer therapies vary due to intertumo
26 with unstable caffeine resistance show cross-resistance to antifungal agents, suggesting that related
27 ous fungal biofilm maturation but also drive resistance to antifungal treatment.
28   While members of this serotype can acquire resistance to antimicrobials, the temporal dynamics of t
29 ies per mL before treatment and no genotypic resistance to any study drugs; secondary analyses elimin
30 metabolic reprogramming, immune suppression, resistance to apoptosis, angiogenesis, metastasis, and i
31 therefore, may promote PCa cell survival and resistance to AR targeting therapeutics.
32 etastatic breast cancer, and confer clinical resistance to aromatase inhibitors.
33 solve this question, the correlation between resistance to ARSi and genetic chances and expression of
34                                              Resistance to at least two drugs was common (196, 83%),
35      Additionally, S. aureus did not develop resistance to auranofin after repeated exposure for two
36                             The emergence of resistance to available antileishmanial drugs advocates
37                         WCR populations with resistance to Bacillus thuringiensis (Bt) toxins utilize
38 tionalized to exhibit chromogenic reactions, resistance to bacterial infection and heat-triggered, en
39 t-derived xenograft (PDX) models of acquired resistance to BCL-2 (venetoclax) and MCL-1 (S63845) anta
40                                         MRSA resistance to beta-lactam antibiotics is mediated by two
41 t-MPN, CD34+ sAML blasts exhibiting relative resistance to BETi, as compared with sensitive sAML blas
42  with numerous human diseases and can confer resistance to both antibiotics and host defenses.
43 re were 90 ART-experienced participants with resistance to both efavirenz and lamivudine, 32 (35.6%)
44                          There were ten with resistance to both tenofovir and lamivudine, 8 (80.0%) o
45 g, which has recently been implicated in the resistance to BRAF and MAPK/ERK kinase inhibitors.
46 eased EGFR protein expression, and conferred resistance to BRAFis both in vitro and in vivo.
47 ites containing platelets showed an enhanced resistance to breaking under strain compared to their sp
48                             Here we analyzed resistance to Bt toxin Cry1Ac in a field-derived strain
49 erminants in Listeria, with special focus on resistance to cadmium and arsenic, as well as to biocide
50 nt NHEJ with implications for development of resistance to cancer therapy.
51 ontribute to the naked mole-rat's remarkable resistance to cancer.
52                                              Resistance to carvacrol has selected for viruses with mu
53                                              Resistance to cavitation (P(50) ), a critical trait for
54                                              Resistance to CDC-induced pore formation requires the pr
55  report that interferon (IFN) signals convey resistance to CDC-induced pores on macrophages and neutr
56 o both CVD and cancer, such as inflammation, resistance to cell death, cellular proliferation, neuroh
57                                           NG resistance to cephalosporins, which is increasingly repo
58                             MIR1249 mediates resistance to CG in BTCs and may be tested as a target f
59 otes hypovascularity, immunosuppression, and resistance to chemo- and immunotherapies.
60  the hypothesis that aneuploidy brings about resistance to chemotherapies because of a general featur
61  poor patient outcomes due to development of resistance to chemotherapy agents and the EGFR inhibitor
62         Our data highlight a role for A3B in resistance to chemotherapy and indicate that stimulation
63  drives aggressive TNBC biology by promoting resistance to chemotherapy and inducing a prometastatic
64 down-regulation of SMPD1 was associated with resistance to chemotherapy regimens that include 5-FU.
65 ls possess the capacity for self-renewal and resistance to chemotherapy.
66 ed with high tumor grade, poor survival, and resistance to chemotherapy.
67 ype but also revealed a potential intestinal resistance to chlamydial spreading.
68                                              Resistance to chlorhexidine, an antiseptic widely used t
69 st-west divide in haplotypes known to confer resistance to chloroquine and sulfadoxine-pyrimethamine.
70  conformation of the trimer) increased virus resistance to cholesterol depletion and to the surface-a
71 positively associated with the prevalence of resistance to ciprofloxacin (P < .05).
72 was achieved despite the bacteria's relative resistance to ciprofloxacin and where an equivalent dose
73                     Our results suggest that resistance to ciprofloxacin is responsive to short-term
74                        Intrinsic or acquired resistance to clinically approved CDK4/6 inhibitors has
75 e support a role for CA activity in reducing resistance to CO(2) diffusion inside mesophyll cells by
76 yzae, hemibiotrophic pathogens, but enhanced resistance to Cochliobolus miyabeanus, a necrotrophic pa
77 li in domestic swine in China that conferred resistance to colistin, an antibiotic of last resort use
78 minates Ph(+) ALL cells including those with resistance to commonly used ABL1 kinase inhibitors.
79        Binding of FH increases meningococcal resistance to complement-mediated killing.
80 c, and mesenchymal tumor phenotype, mediates resistance to conventional therapies and small-molecule
81 sion, thus underlying disease recurrence and resistance to conventional therapies, and we detail our
82 ess in solid tumors associated with acquired resistance to conventional therapy.
83  operon that plays important roles in cells' resistance to copper/silver, and they belong to the two-
84                               The widespread resistance to Cry1 and Cry2 proteins in H. zea will chal
85  the primary, but not the only, mechanism of resistance to Cry2Ab in pink bollworm.
86 X-R has at least one additional mechanism of resistance to Cry2Ab that does not involve PgABCA2 and i
87                   We then show that acquired resistance to CX-5461 in previously sensitive lymphoma c
88 superior catalytic performance and increased resistance to deactivation by coking, compared to its mi
89 xtended due to delayed neurodegeneration and resistance to death upon fasting.
90 esults from forces required to overcome soil resistance to deformation.
91 dramatically enhanced (sometimes >1000 fold) resistance to degradation by four different nucleases, b
92 ced immediately after calving, have enhanced resistance to degradation by intestinal proteases relati
93 scle-type nAChRs but showed greatly improved resistance to degradation in human serum and, surprising
94 hibition of both RET and VEGFR2, as well the resistance to demethylation, renders NPA101.3 a potentia
95                     BMAds, in turn, provided resistance to dexamethasone-induced cell-cycle arrest an
96 rotubules contribute meaningful viscoelastic resistance to diastolic stretch in human myocardium.
97 ensity or detyrosination lowers viscoelastic resistance to diastolic stretch in human myocytes and my
98        The first suggests that longevity and resistance to diseases are mediated by shared mechanisms
99  between Cu(I) and Cu(II) , as well as their resistance to dissociation or inactivation under cytosol
100 enes whose loss causes either sensitivity or resistance to DNA-damaging agents.
101 ECT2, that participate to breast cancer cell resistance to doxorubicin.
102 ed in a breast cancer cell model of acquired resistance to doxorubicin.
103 ffectors that can lead to the development of resistance to drug inhibitors.
104 iation, but increases (decreases) in disease resistance to E. muscae are not consistently associated
105 rvation of S6K1 as a candidate mechanism for resistance to EGFR TKI therapy was investigated by inter
106                           The development of resistance to EGFR Tyrosine kinase inhibitors (TKIs) in
107 l unexpected features, including significant resistance to electrically-induced limbic seizures and t
108 tionary integration between conductivity and resistance to embolism, rejecting a hardwired trade-off
109  correlated with phenotypic AMR testing, and resistance to empirical antimicrobials was associated wi
110 lusion criterion was a history of documented resistance to enfuvirtide.
111 stomatous and a major target for desiccation resistance to enhance shelf life.
112 e availability of free amino acids increases resistance to environmental stresses.
113 terize in vitro and in vivo the response and resistance to enzalutamide.
114  scan" yielded peptidomimetics with improved resistance to enzymatic degradation and/or enhanced affi
115 armacological properties, including improved resistance to enzymatic degradation, while remaining non
116  to 24 h to elucidate differences in scleral resistance to enzymatic degradation.
117              It was also related to a higher resistance to enzyme hydrolysis of the retrograded starc
118 nally, R649W(+/-) cells exhibited a dramatic resistance to ER stress-dependent apoptosis.
119      TRPV3 overexpression in HBECs conferred resistance to ERS and an attenuation of ERS-associated c
120 NA gene mutations causing variable levels of resistance to erythromycin.
121 ential targets for circumvention of acquired resistance to etoposide.
122 rotein 170 kDa expression levels in acquired resistance to etoposide.
123 n-producing species because it exhibits self-resistance to exogenous echinocandins.
124 ult of STAT5 deficiency displayed a profound resistance to experimental autoimmune encephalomyelitis.
125 2OGO knock-out (KO) mutants display enhanced resistance to Fg in a detached inflorescence infection a
126 3K pathway is essential to overcome Melanoma resistance to fotemustine.
127                                     Acquired resistance to fulvestrant and palbociclib is a new chall
128 thione S-transferase (GST) and confers broad resistance to Fusarium species by detoxifying trichothec
129 lymphoblastic leukemia (T-ALL), and although resistance to GCs is a strong negative prognostic indica
130  cells that overexpressed ZIP4 had increased resistance to gemcitabine, 5-fluorouracil, and cisplatin
131 ch based on targeting the very mechanisms of resistance to gemcitabine, a commonly used chemotherapeu
132 K5/ERK5 signaling pathway is associated with resistance to genotoxic stress in aggressive prostate ca
133                           Here, we show that resistance to glyphosate in the studied population from
134 spora led to high CAT-3 expression level and resistance to H(2) O(2) -induced ROS stress.
135 redoxin, Tsa1 is required for both promoting resistance to H(2)O(2) and extending lifespan upon calor
136 veterinary professionals may need to include resistance to heat-related illness amongst their rationa
137 that determine clinically relevant delamanid resistance to help develop a rapid delamanid DST.
138 highly accurate and robust classification of resistance to HIV protease inhibitors.
139 of second-generation antiandrogens, acquired resistance to hormone therapy remains a major challenge
140 large polyploid cells that exhibit increased resistance to host immune attack and are proposed to con
141  of outer membrane porin OmpT, which confers resistance to host-derived antimicrobial peptides and bi
142 ride (LPS)(6) enhance lethality by promoting resistance to human innate immunity and antibiotics, ena
143 arette smoke extract (CSE) exposure enhances resistance to human neutrophil killing, but this increas
144 gulator, ToxR, was important for V. cholerae resistance to hydrogen peroxide.
145 t Renca subcutaneous tumors in mice are more resistance to ICB, and a retrospective analysis of the I
146 lass I (MHC-I), which has been implicated in resistance to immune checkpoint blockade (ICB) therapy(1
147 overexpressing tumors and is associated with resistance to immune checkpoint inhibitors.
148               Identifying factors underlying resistance to immune checkpoint therapy (ICT) is still c
149 h ought to be eliminated to revert intrinsic resistance to immunotherapeutic intervention.
150                                     However, resistance to immunotherapy occurs for many patients, re
151                However, primary or secondary resistance to immunotherapy prevents benefits in a signi
152 beta2-AR signaling could be used to increase resistance to infectious diseases.
153  contributes to phenotypic variation such as resistance to infectious diseases.
154 tic tool is leading to the profiling of drug resistance to inform clinical practice and treatment dec
155 n between 5-HT(3A) and the chaperone protein resistance to inhibitors of choline esterase (RIC-3).
156 al S1PR1 angiocrine signaling causes reduced resistance to injury-induced vascular leak and leads to
157 Malaria vector control may be compromised by resistance to insecticides in vector populations.
158                          However, increasing resistance to insecticides threatens to undermine these
159 ring these conditions, lactulose showed high resistance to intestinal digestion by RSIE, resulting in
160                       External stability, or resistance to invasion, is thus an important but overloo
161 er-expressed in multiple cancers and confers resistance to ionizing radiation and chemotherapeutic dr
162  resistance results available, 195 (82%) had resistance to lamivudine, 128 (54%) to tenofovir, and 21
163 notyping to assess their potential to confer resistance to LET.
164 ant community and may contribute to creating resistance to LKD.
165  dipeptides into cross-bridges and to confer resistance to lysostaphin, a secreted bacteriocin that c
166 s to dwarfism, mild cell death, and enhanced resistance to M. oryzae in the non-Piz-t background.
167                                              Resistance to macrolide antibiotics is a global concern
168 assembling block copolymers exhibit superior resistance to macroscopic deformation in comparison to t
169 Its genetic hallmark, the mecA gene, confers resistance to many beta-lactam antibiotics.
170     NRAS-driven melanomas frequently develop resistance to MAPK/extracellular signal-regulated kinase
171 e created trametiglue, which limits adaptive resistance to MEK inhibition by enhancing interfacial bi
172                             Through modeling resistance to MET kinase inhibition in cultured cancer c
173 wing slowly under nutrient limitation and to resistance to microbial decomposition.
174             TFEB oligomers display increased resistance to mTORC1-mediated inactivation and are more
175                          However, increasing resistance to multiple antibiotics may necessitate waiti
176 xpressed, one of these lipoproteins promotes resistance to multiple bacteriophages.
177                                              Resistance to multiple insecticides in An. gambiae s.s.
178 uced spontaneous tumorigenesis and increased resistance to Myc-driven lymphoma and Eml4-Alk-driven lu
179 stitutive overexpression of genes related to resistance to myrtle rust caused by A. psidii.
180 d genes may contribute to their differential resistance to NDV and also to understanding the interact
181 ne response could contribute to differential resistance to NDV in inbred Fayoumi and Leghorn lines.
182 s, which have recently proven vital in plant resistance to necrotrophic fungal pathogens.
183 his increase in pathogenicity was not due to resistance to neutrophil extracellular traps.
184 esistance loci, encoding enzymes that confer resistance to nonrelated antibiotics, including extended
185               We show that, in difference to resistance to nucleotide analogs, which is mainly associ
186  previously unknown host factors that confer resistance to one or more of these phages.
187                          We modeled acquired resistance to osimertinib in transgenic mouse models of
188  as a therapeutic strategy to overcome tumor resistance to osimertinib.
189 ction of ampicillin resistance and the cross-resistance to other antibiotics (i.e., ciprofloxacin, ch
190 ins, emergent beta-lactamases can now confer resistance to other beta-lactam drugs, including both ce
191 r in AIVs with substitutions known to impart resistance to other NAIs.
192 sulted from the site morphology having a low resistance to overwash, as opposed to being directly imp
193 tly associated with increases (decreases) of resistance to oxidative stress, starvation stress and sl
194 ly promising strategy for OVCAs that acquire resistance to PARPi and platinum.
195 f-function of HOS15 or HDA9 confers enhanced resistance to pathogen infection accompanied with increa
196 ortant indicator of soybean productivity and resistance to pathogens in adverse climates.
197  breeding next-generation crops with durable resistance to pathogens is achievable, and will be a key
198 otion, nutrient uptake, stress tolerance and resistance to pathogens.
199 omal alterations associated with response or resistance to PD-1 blockade.
200                 BQ11 demonstrated high-level resistance to penicillin (benzylpenicillin MIC >= 256 mu
201 ed PGRP-induced H(2)O(2) production and high resistance to PGRP-induced killing.
202                                              Resistance to Phytophthora crown rot in University of Fl
203 TLs significantly (P < 0.05) associated with resistance to Phytophthora crown rot were detected on ch
204 cooperates with laminin and hypoxia to drive resistance to PI3K inhibitors.
205 n following drug treatment is a biomarker of resistance to PI3Kalpha inhibition in ER(+) breast cance
206  clinically viable strategies for overcoming resistance to platinum chemotherapy in lung adenocarcino
207 e valuable for understanding acquired tumour resistance to poly(ADP-ribose) polymerase (PARP) inhibit
208 y mobile genetic elements, thus transferring resistance to previously susceptible bacterial strains.
209                                              Resistance to pyrazinamide is largely driven by mutation
210  second-line TB medication exposure, or drug resistance to pyrazinamide, ethambutol, kanamycin, moxif
211 show alarming increases in the prevalence of resistance to pyrethroids and DDT across sub-Saharan Afr
212 s has precipitated widespread and escalating resistance to pyrethroids in African Anopheles populatio
213 ations in gyrA and parC recognized to confer resistance to quinolones.
214  overexpressed, while FBL55 OE plants showed resistance to R. solani challenge.
215 r NHFs stimulate proliferation of and confer resistance to radiation therapy of PDAC.
216 elated with their enhanced proliferation and resistance to radiation therapy.
217 were observed, from long-term maintenance of resistance to rapid return to sensitivity after daptomyc
218 4 nuclear receptor might alter the sunitinib resistance to RCC via altering the TR4/lncTASR/AXL signa
219 he V557L mutation is implicated in low-level resistance to RDV.
220 est that ToxR plays an important role in the resistance to reactive oxygen species through the regula
221  for third-line ART in LMIC, ranging from no resistance to resistance to 3 drug classes.
222 tied to mangroves' carbon sink functions and resistance to rising sea levels.
223 west scan speeds showed comparable corrosion resistance to rolled and annealed super duplex stainless
224         Intrinsic or extrinsic mechanisms of resistance to ROS1 TKIs can emerge in patients.
225 ransgenic overexpression of NbP3IP conferred resistance to RSV infection in Nicotiana benthamiana.
226 e or combined strategies that might overcome resistance to RTK inhibitors in patients with cancer.
227 icrobiomes conferred the strongest herbivore resistance to S. altissima plants in a glasshouse experi
228 nent of humoral innate immunity, involved in resistance to selected pathogens and in the regulation o
229 sed to be a major contributor to the rise of resistance to several classes of antimalarial drugs.
230         Furthermore, XPO1 is associated with resistance to several standard-of-care therapies, includ
231 amma-producing ILCs also improve endometrial resistance to sexually transmitted C. trachomatis infect
232 s viral infections, IRF3 is also involved in resistance to some bacterial infections, in anticancer i
233 tinfection, B cell deficiency alone enhanced resistance to splenic infection ~100-fold; however, comb
234 sidues, we found that the genetic barrier to resistance to stem bnAbs is low for the H3 subtype but s
235 duced gene co-silencing resulted in enhanced resistance to stem rust.
236 ding on ileum villi and PP FAE that mediates resistance to STm infection.
237 ergence of mutants with significantly higher resistance to streptomycin; (2) the exposure to pesticid
238 heritable gene expression state that enables resistance to stress.
239 nd integrity of the nuclear envelope and its resistance to stresses found that both mutations result
240 resistance (MDR) in cancer arises from cross-resistance to structurally- and functionally-divergent c
241 ed HCC and to identify predictors of primary resistance to systemic therapies using circulating tumor
242                          Understanding tumor resistance to T cell immunotherapies is critical to impr
243  in treating patients with advanced BC after resistance to TAM and aromatase inhibitors develops.
244 on of ER-positive breast cancer patients and resistance to tamoxifen treatment.
245 her intrinsically resistant or have acquired resistance to targeted therapies and immunotherapies.
246 paired proteostasis and rapid development of resistance to targeted therapy that represent a major cl
247                        There is no known HBV resistance to TDF.
248                   In this study, we profiled resistance to the anti-influenza drug laninamivir in AIV
249 odulates host-pathogen interactions, such as resistance to the bacteriolytic activity of lysozyme, vi
250 ram-negative bacterial pathogens and provide resistance to the cephalosporin cefotaxime but not to th
251  of APE1 recruitment to stalled RFs promoted resistance to the chemotherapeutic cisplatin.
252   Due to the constant emergence of parasitic resistance to the current antimalarial drugs, the discov
253 ted adherence to ART and the absence of drug resistance to the current ART regimen.METHODSSamples wer
254 re that long-term, moderate hypoxia promotes resistance to the EGFR TKI osimertinib (AZD9291) in the
255 esistant bacterium in the United States, and resistance to the frontline treatments is well documente
256 described in Streptomyces as a means of self-resistance to the genotoxic natural product azinomycin B
257 EIN (CtBP), antagonistically regulates plant resistance to the hemibiotrophic pathogen Pseudomonas sy
258 ession of Rac1 is associated with multi-drug resistance to the neoadjuvant chemotherapy (NAC).
259 ual body motion reduced the initial in-place resistance to the perturbation.
260 e squirrelpox virus-encoded vMISTRAV exhibit resistance to the same insults.
261                           Glioblastoma (GBM) resistance to the standard of care is prompting scientis
262  sensitive lymphoma cells confers collateral resistance to the topoisomerase II poison doxorubicin.
263 s study sheds evident contrasts of bacterial resistance to the two most common heavy metals.
264 osylation (ghmC) exhibits various degrees of resistance to the type V CRISPR-Cas12a system, producing
265 d (Triticum aestivum L.) wheat that provides resistance to the wheat stem sawfly.
266 and nucleotides for biosynthesis, conferring resistance to therapies targeting anabolic pathways.
267 or mass and plays various roles in promoting resistance to therapies.
268 l types in the tumor, drive tumor growth and resistance to therapies.
269 s, thereby increasing GSC tumorigenicity and resistance to therapies.
270  carrying mutations in genes responsible for resistance to therapy has led to a Darwinian model of cl
271 vances in melanoma treatment, metastasis and resistance to therapy remain serious clinical challenges
272 ion for their role in cancer progression and resistance to therapy.
273 hways cooperate to promote tumorigenesis and resistance to therapy.
274 s associated with worse clinical outcome and resistance to therapy.
275 iotics, but they were also unable to develop resistance to these antibiotics in laboratory experiment
276                      Candida showed relative resistance to these compounds, requiring high concentrat
277 onse is almost always temporary and acquired resistance to these drugs invariably emerges.
278 ing indicate a high rate of de novo acquired resistance to these drugs relative to pre-existing resis
279 unity, and divergence of female genotypes in resistance to these effects.
280 rgeted antibodies and kinase inhibitors, but resistance to these therapies leads to systemic tumor re
281 nd a substantial proportion of patients show resistance to these therapies, the beneficial effects of
282 t brown rice and split pea soup demonstrated resistance to thiamine degradation, while thiamine in be
283 re phenotyped for flowering time, height and resistance to three foliar diseases, and genotyped with
284 suggests a potential mechanism of developing resistance to topoisomerase poisons by ensuring rapid TO
285  to heavy metal remediation depends on their resistance to toxic metals.
286 OM) of gram-negative bacteria confers innate resistance to toxins and antibiotics.
287 isms underlying TRAIL-mediated apoptosis and resistance to TRAIL.
288  is implicated in tumorigenesis and acquired resistance to treatments.
289 ding sites, conferring extreme physiological resistance to TTX.
290 onse to stimuli, and inflammation can impact resistance to tumorigenesis in DS patients.
291  monoubiquitination of eS7A was required for resistance to tunicamycin, whereas E3 ligase Hel2-mediat
292                         In particular, cross-resistance to unrelated classes may occur by co-selectio
293 ween the catalytic activity of a MOF and its resistance to unzipping.
294                                              Resistance to updating beliefs with new information has
295 directly address the underlying mechanism of resistance to vancomycin.
296 transmitted by nematodes linking Nb-mediated resistance to vector transmission.
297  from the F(2) screen showed a high level of resistance to Vip3Aa39 protein, with a resistance ratio
298                    The cocktail demonstrated resistance to virus escape and protected non-human prima
299 ture of the nitroxides must confer reduction resistance to withstand the reductive environment within
300  Mediterranean populations confer heightened resistance to Y. pestis.

 
Page Top